Characterisation of NK cells and other cytotoxic killer cells in atopic dermatitis using single cell RNA sequencing
Characterisation of NK cells and other cytotoxic killer cells in atopic dermatitis using single cell RNA sequencing
批准号:
497917553
负责人:
Professor Dr. Stephan Weidinger
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
多种免疫细胞亚型如T细胞,特别是Th2细胞、巨噬细胞和树突状细胞在特应性皮炎(AD)患者病变皮肤中的积累已知对皮肤炎症具有维持作用,而一些细胞类型似乎具有调节功能。最近,在独立的中重度AD患者中观察到外周血自然杀伤细胞(NK)总量显著减少,成熟CD56dim CD57+ NK细胞缺失,病变皮肤中活化NK细胞转录组特征富集。此外,在小鼠AD模型中,促进NK细胞的存活和增殖可减少炎症以及2型先天淋巴样细胞(ILC2)和嗜酸性粒细胞的数量。基于这些观察,我们推测在AD中,NK细胞是否作为对2型皮肤炎症的内源性反调节反应从外周募集到发炎的皮肤,然而,它们也可能具有炎症促进作用。到目前为止,还没有在AD的背景下进行深入和纵向的组织NK细胞表型分析。该项目旨在全面定义AD患者皮肤和血液中单细胞水平NK细胞异质性,检测NK细胞效应物功能,并分析抗il4r α抗体dupilumab和抗il13抗体tralokinumab对2型阻断的影响。
英文摘要
The accumulation of multiple immune cell subtypes such as T cells, in particular Th2 cells, macrophages, and dendritic cells in lesional skin of patients with atopic dermatitis (AD) is known to have a sustaining role for the inflammation of the skin, while some cell types appear to have a regulatory function. Recently, a marked reduction of total peripheral blood natural killer (NK) cells along with a loss of mature CD56dim CD57+ NK cells and an enrichment of activated NK cell transcriptomic signatures in lesional skin has been observed in independent sets of patients with moderate to severe AD. Further, in a murine AD model, promotion of the survival and proliferation of NK cells reduced inflammation as well as the number of type 2 innate lymphoid cells (ILC2) and eosinophils. Based on these observations it has been speculated whether in AD, NK cells are recruited from the periphery to the inflamed skin as an endogenous counterregulatory response to type 2 skin inflammation, however, they could as well have inflammation promoting effects. So far, no in-depth and longitudinal NK cell phenotyping across tissues has been carried out in the context of AD. The proposed project aims at comprehensively defining NK cell heterogeneity at the single-cell level in both skin and blood of patients with AD, to examine NK cell effector functions, and to analyse the effects of type-2 blockade with the anti-IL4Rα antibody dupilumab and the anti-IL13 antibody tralokinumab.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of host genetic variation and environmental influences on the cutaneous microbiome composition
-
批准号:387771232
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Professor Dr. Stephan Weidinger
-
依托单位:
Follow-up functional studies on a risk variant for atopic dermatitis on chromosome 11q13.5 identified by genome-wide association studies
-
批准号:197185106
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Professor Dr. Stephan Weidinger
-
依托单位:
Verlängerungsantrag Heisenberg-Professur
-
批准号:173936455
-
项目类别:Heisenberg Professorships
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Stephan Weidinger
-
依托单位:
Untersuchung hereditärer Suszeptibilitätsfaktoren des atopischen Ekzems
-
批准号:91925043
-
项目类别:Heisenberg Fellowships
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Stephan Weidinger
-
依托单位:
Finemapping of susceptibility loci for atopic dermatitis on chromosome 1q21.3 and chromosome 11q13.5
-
批准号:122822702
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Stephan Weidinger
-
依托单位:
国内基金
海外基金
登录
查看更多内容
记忆性NK细胞在肿瘤微环境中的跨物种代谢动态图谱研究
-
批准号:2026JJ50431
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:熊佩文
-
依托单位:
基于多组学与可视化免疫动态成像技术解析EZH2抑制对增强CAR-NK细胞抗AML效应的机制研究
-
批准号:JCZRLH202600775
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
腺苷经嘌呤补救途径代谢促进NK细胞免疫抑制的机制研究
-
批准号:2026JJ60615
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:田宇茜
-
依托单位:
抑制IGSF8解除围术期氯胺酮对NK细胞抑制增强肝癌抗肿瘤免疫效应的机制研究
-
批准号:JCZRLH202600798
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
CD49a+ NK细胞在急性胰腺炎重症化中的作用及机制研究
-
批准号:2026JJ30165
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭超超
-
依托单位:
CD19/BCMA双靶向CAR-NK细胞治疗难治性SLE:作用机制与临床前转化研究
-
批准号:2026JJ81339
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢希
-
依托单位:
SLC3A2/CD98 通过代谢重编程增强MSLN-TLR4-CAR-NK 细胞对卵巢癌细胞杀伤作用的机制研究
-
批准号:JCZRLH202600695
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
从NKG2D与sMICA“交互效应”介导的肿瘤细胞逃避NK细胞杀伤现象研究白藜芦醇改善肝癌“正虚邪实”病理状态的免疫学机制
-
批准号:2026JJ60557
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱权
-
依托单位:
新型EZH2i重塑NK/T细胞淋巴瘤免疫代谢微环境的分子机制及疗效标志物探索
-
批准号:82675067
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:周辉
-
依托单位:
CiPSC分化来源的NK细胞联合放/化疗在结肠癌中的应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:肖雄
-
依托单位: